J. Stark Thompson Phd

Insider Reports History

Entity
Individual
Signature
/s/ Katie A. Kazem, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by J. Stark Thompson Phd:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MAXCYTE, INC. Director Common Stock 111K $502K $4.53 Jul 29, 2021 Direct
MAXCYTE, INC. Director Stock Option (right to buy) 10K Aug 9, 2021 Direct

Insider Reports Filed by J. Stark Thompson Phd

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MXCT MAXCYTE, INC. Aug 9, 2021 1 $0 4 Aug 11, 2021 Director
MXCT MAXCYTE, INC. Jul 29, 2021 0 $0 3 Jul 29, 2021 Director